scholarly article | Q13442814 |
P50 | author | Brandon L Findlay | Q93208988 |
P2093 | author name string | Nour Ghaddar | |
Mona Hashemidahaj | |||
P2860 | cites work | Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection | Q22122301 |
Spatiotemporal microbial evolution on antibiotic landscapes | Q26844386 | ||
Bacterial Responses and Genome Instability Induced by Subinhibitory Concentrations of Antibiotics | Q27008535 | ||
The complete genome sequence of Escherichia coli K-12 | Q27860542 | ||
A constant rate of spontaneous mutation in DNA-based microbes | Q28271032 | ||
Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium | Q50127629 | ||
A theoretical examination of the relative importance of evolution management and drug development for managing resistance. | Q51015217 | ||
Growth rates made easy. | Q51147152 | ||
Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics. | Q52655481 | ||
Role of mutator alleles in adaptive evolution. | Q54564129 | ||
Death and population dynamics affect mutation rate estimates and evolvability under stress in bacteria. | Q55162233 | ||
Mutational Pathway Determines Whether Drug Gradients Accelerate Evolution of Drug-Resistant Cells | Q59444106 | ||
Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set | Q77465460 | ||
Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments | Q84975610 | ||
Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy | Q28544732 | ||
Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance | Q28551034 | ||
Evaluation of the characteristics of leucyl-tRNA synthetase (LeuRS) inhibitor AN3365 in combination with different antibiotic classes | Q28597744 | ||
On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. | Q30519515 | ||
Determining the limits of the evolutionary potential of an antibiotic resistance gene | Q30912402 | ||
Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes | Q33320960 | ||
Resistance to trimethoprim-sulfamethoxazole | Q33945728 | ||
Fitness cost of chromosomal drug resistance-conferring mutations | Q34107494 | ||
AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants | Q34370243 | ||
Antibiotic resistance-the need for global solutions | Q34386251 | ||
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances | Q34750112 | ||
Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections. | Q34922438 | ||
Normal mutation rate variants arise in a Mutator (Mut S) Escherichia coli population. | Q34998550 | ||
Migration of chemotactic bacteria in soft agar: role of gel concentration | Q35132792 | ||
Resistance to β-lactam antibiotics conferred by point mutations in penicillin-binding proteins PBP3, PBP4 and PBP6 in Salmonella enterica. | Q35165526 | ||
Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics | Q35215053 | ||
Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance | Q35699612 | ||
Development of potent in vivo mutagenesis plasmids with broad mutational spectra | Q36249749 | ||
Mechanisms of reduced susceptibility to ciprofloxacin in Escherichia coli isolates from Canadian hospitals | Q36333597 | ||
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection | Q36500996 | ||
AmpC beta-lactamases | Q37366249 | ||
Bacterial hypermutation: clinical implications | Q37847007 | ||
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide | Q38220361 | ||
Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome | Q38355288 | ||
LrhA as a new transcriptional key regulator of flagella, motility and chemotaxis genes in Escherichia coli. | Q38364145 | ||
Prediction of antibiotic resistance: time for a new preclinical paradigm? | Q38649580 | ||
One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams | Q38712471 | ||
Evolution of Resistance to Continuously Increasing Streptomycin Concentrations in Populations of Escherichia coli | Q38740945 | ||
The Role of Reactive Oxygen Species in Antibiotic-Mediated Killing of Bacteria | Q39019848 | ||
Antibiotic uptake into gram-negative bacteria | Q39309521 | ||
Two complementation groups mediate tetracycline resistance determined by Tn10 | Q39984225 | ||
Adaptive tuning of mutation rates allows fast response to lethal stress in Escherichia coli | Q40230898 | ||
Selective compartments for resistant microorganisms in antibiotic gradients | Q40885917 | ||
Mutational Consequences of Ciprofloxacin in Escherichia coli | Q41194789 | ||
Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution | Q42054011 | ||
High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
The Search for 'Evolution-Proof' Antibiotics | Q49391302 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibiotic resistance | Q380775 |
P304 | page(s) | 17023 | |
P577 | publication date | 2018-11-19 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Access to high-impact mutations constrains the evolution of antibiotic resistance in soft agar | |
P478 | volume | 8 |
Search more.